Co-Authors
This is a "connection" page, showing publications co-authored by NANDITA GUHA-THAKURTA and ISABELLA CLAUDIA GLITZA.
Connection Strength
1.528
-
Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient. J Neurooncol. 2017 Jul; 133(3):663-665.
Score: 0.591
-
Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med. 2024 Jun; 30(6):1787.
Score: 0.241
-
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med. 2023 04; 29(4):898-905.
Score: 0.222
-
Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD). J Neurooncol. 2019 May; 142(3):499-509.
Score: 0.167
-
Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2. ESMO Open. 2018; 3(1):e000283.
Score: 0.155
-
Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases. Melanoma Res. 2017 12; 27(6):580-584.
Score: 0.153